Company intelligence / Profile preview

ETAO International

New York, New York, United Statesprnewswire.com ↗

Ownership: Public · ETAO
Development stage: Other

Overview

ETAO operates a digital healthcare ecosystem combining online telemedicine, AI-driven health solutions, and offline specialized hospitals. The company has expanded through strategic acquisitions to enhance its global capabilities. It focuses on providing accessible medical care using advanced biomedical technologies in China and internationally. No clinical trial results are reported as it does not develop drugs or biologics.

Industry: Non-Academic Healthcare

Partnerships

Alibaba Group

Financials

Market cap: $9.8M
Total revenue: $58.1M
Enterprise value: $10.9M

Beyond the preview

Go deeper on ETAO International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ETAO International.

Explore the full profile